Sun Nelson sold 76,754 Aardvark Therapeutics shares in two transactions priced from $5.00 to $5.18 per share. The reported activity leaves Nelson with 35,475 shares, giving investors the stated post-sale ownership position alongside transaction dates of 2026-09-10 and 2026-09-11.

Key Highlights

  • The transactions were priced between $5.00 and $5.18 per share.
  • Both entries carried transaction code S and occurred on 10 September 2026 and 11 September 2026.
  • Sun Nelson held 35,475 Aardvark Therapeutics shares after the transactions.

Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares were sold by Sun Nelson in two transactions involving 76,754 shares. The reported sales leave Nelson with a stated post-transaction holding in the company’s shares.

Sale Prices and Transaction Classification

Both entries carried transaction code S. The disclosed activity involved Aardvark Therapeutics shares and covered two separate transactions. The price range applies to the shares sold in the reported transactions. The filing reports the transactions as sales and lists code S for each entry, while the named company associated with the position is Aardvark Therapeutics, Inc.

Reported Ownership After the Transactions

The transaction dates were 10 September 2026 and 11 September 2026. After the transactions, Sun Nelson’s reported ownership stood at 35,475 shares. That figure represents the stated holding following the sales. The ownership information refers to Aardvark Therapeutics shares, the same security involved in the transactions. Transaction code S denotes an open-market or private sale.